This research compound combines CJC-1295, a Growth Hormone-Releasing Hormone (GHRH) analog, with Ipamorelin, a selective ghrelin receptor agonist. Together, they are commonly studied for their complementary roles in growth hormone signaling and endocrine regulation.
Researchers use this combination to explore how different pathways interact in regulating hormone release, metabolic processes, and cellular response mechanisms.
The precise 1:1 formulation allows for consistent experimental conditions, making it suitable for both in vitro and preclinical research environments.
Specifications
- Form: Lyophilized powder
- Total Content: 10mg (5mg / 5mg blend)
- Purity: ≥98% (batch-dependent)
Disclaimer
For research use only. Not intended for human or animal consumption.




Reviews
There are no reviews yet.